PCA Loading Time Before Knee Prosthetic Joint Infection Revision

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorDr. Dean Reeves Clinic

About this trial

Proof of principle pilot study of the effect of dietary nutritional loading of protocatechunic acid (PCA) on the health and welfare of individuals with prosthetic joint infection (PJI), as measured by standard biomarkers

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

More than 3 weeks after total knee arthroplasty

One or more symptoms of injection, including redness, swelling, pain, increasing range of motion loss, fever, nausea, and loss of appetite.

WBC count of aspiration >50,0000 cells per μL

Disqualifiers

None

Trial design

Design model

Single group

Treatments tested in this trial

  • Oral PCA

    Dietary supplement

    Administration of 1,000 mg BID of oral PCA in individuals with knee prosthetic joint infection prior to revision surgery

Treatment groups

10 Participants
are divided into 1 treatment group
Group A: Oral PCAOther 1 intervention

Trial outcomes

Primary outcomes

1

Change in Walking Pain 0-10 NRS

Walking pain change from time 0 to weekly follow-ups from 1-4

Time frame
0,1, 2, 3, and 4 weeks
2

Change in CRP

Blood CRP change from time 0 to weekly follow-ups from 1-4

Time frame
0,1, 2, 3, and 4 weeks
3

Change in ESR

Blood ESR change from time 0 to weekly follow-ups from 1-4

Time frame
0,1, 2, 3, and 4 weeks
4

Change in WBC count in aspirate

Total WBC count change in periprosthetic aspirate

Time frame
0,1, 2, 3, and 4 weeks

Secondary outcomes

1

CXCL9

Change in Immunity Factor CXCL9 from 0 to 3 months

Time frame
0 and 3 months
2

HbA1c

Change in HbA1c from 0 to 3 months

Time frame
0 and 3 months

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Dr. Dean Reeves Clinic

Lead sponsor

Lanny Johnson, M.D.

Collaborator

Leo Whiteside, M.D.

Collaborator

This trial is not recruiting at the moment. You can still explore other options: